Adalimumab maintains remission for up to 4 years in patients with ulcerative colitis

被引：0
|
作者：
Colombel, J. -F. [1 ]
Sandborn, W. J. [2 ]
Ghosh, S. [3 ]
Wolf, D. [4 ]
Panaccione, R. [3 ]
Feagan, B. [5 ]
Reinisch, W. [6 ]
Robinson, A. M. [7 ]
Lazar, A. [8 ]
Kron, M. [8 ]
Huang, B. [7 ]
Thakkar, R. B. [7 ]
机构：
[1] Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY 10029 USA
[2] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA
[3] Univ Calgary, Dept Med, Calgary, AB, Canada
[4] Atlanta Gastroenterol Associates, Atlanta, GA USA
[5] Robarts Res Inst, London, ON N6A 5C1, Canada
[6] McMaster Univ, Dept Med, Hamilton, ON, Canada
[7] AbbVie Inc, GPRD, N Chicago, IL USA
[8] AbbVie Deutschland GmbH & Co KG, GPRD, Ludwigshafen, Germany
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60691-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P571
引用
收藏
页码：S306 / S306
页数：1
相关论文
共 50 条
  • [41] Adalimumab: A Review of Its Use in the Treatment of Patients with Ulcerative Colitis
    Celeste B. Burness
    Gillian M. Keating
    [J]. BioDrugs, 2013, 27 : 247 - 262
  • [42] Adalimumab: A Review of Its Use in the Treatment of Patients with Ulcerative Colitis
    Burness, Celeste B.
    Keating, Gillian M.
    [J]. BIODRUGS, 2013, 27 (03) : 247 - 262
  • [43] Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis
    Colombel, Jean-Frederic
    Osterman, Mark T.
    Thorpe, Andrew J.
    Salese, Leonardo
    Nduaka, Chudy I.
    Zhang, Haiying
    Lawendy, Nervin
    Friedman, Gary S.
    Quirk, Daniel
    Su, Chinyu
    Reinisch, Walter
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (01) : 116 - +
  • [44] Crypts in Asymmetric Branching in Patients With Ulcerative Colitis in Remission
    Rubio, Carlos A.
    Vieth, Michael
    Lang-Schwarz, Corinna
    [J]. ANTICANCER RESEARCH, 2022, 42 (09) : 4493 - 4497
  • [45] Predictors of Deep Remission in Patients With Inactive Ulcerative Colitis
    Rosenberg, Laura N.
    Lawlor, Garrett
    Gifford, Anne E.
    Falchuk, Kenneth R.
    Wolf, Jacqueline L.
    Cheifetz, Adam S.
    Moss, Alan C.
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S660 - S661
  • [46] Assessment of Lactose Intolerance in Ulcerative Colitis Patients on Remission
    Ahishali, E.
    Akkus, E. E.
    Dolapcioglu, C.
    Sayiner, M.
    Arslan, T.
    Yilmaz, R.
    Kural, A.
    Dabak, R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S351 - S351
  • [47] Safety of Adalimumab in Global Clinical Trials of Ulcerative Colitis Patients
    Colombel, Jean-Frederic
    Ghosh, Subrata
    Sandborn, William
    Van Assche, Gert A.
    Reinisch, Walter
    Lazar, Andreas
    Eichner, Samantha
    Huang, Bidan
    Robinson, Anne
    Thakkar, Roopal
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S231 - S232
  • [48] Is infliximab effective for induction of remission in patients with ulcerative colitis?
    Lichtenstein, GR
    [J]. INFLAMMATORY BOWEL DISEASES, 2001, 7 (02) : 89 - 93
  • [49] Real-world effectiveness of adalimumab in patients with ulcerative colitis
    Armuzzi, A.
    Taxonera, C.
    Panes, J.
    Lakatos, P.
    Fisseha, N.
    Pappalardo, B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S280 - S282
  • [50] Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis
    Singh, S.
    Heien, H. C.
    Sangaralingham, L. R.
    Schilz, S. R.
    Kappelman, M. D.
    Shah, N. D.
    Loftus, E. V.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (09) : 994 - 1003
12345